Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?

被引：0
|
作者：
Nieves Castellanos, C. [1 ]
Losada Lopez, M. [1 ]
Fabrich Marin, M. I. [1 ]
Perez Garcia, J. [1 ]
Diaz Insa, S. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe Valencia, Valencia, Spain
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0105
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
    Van der Arend, Britt W. H.
    Van Veelen, Nancy
    De Ruijter, Joelle E. T.
    Olsen, Michael H.
    MaassenVanDenBrink, Antoinette
    Terwindt, Gisela M.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [22] d Anti-CGRP treatment in difficult-to-treat chronic migraine patients
    di Cola, F. Schiano
    Caratozzolo, S.
    Bolchini, M.
    Ceccardi, G.
    Cortinovis, M.
    Liberini, P.
    Rao, R.
    Padovani, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 589 - 589
  • [23] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Hugo Sevivas
    Paula Fresco
    European Journal of Medical Research, 27
  • [24] Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
    Negro, Andrea
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 769 - 776
  • [25] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Sevivas, Hugo
    Fresco, Paula
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [26] A case of sporadic hemiplegic migraine treated with eptinezumab: should we consider anti-CGRP antibodies for selected patients?
    Antenucci, Pietro
    Pes, Federica
    Cesnik, Edward
    Capone, Jay Guido
    Padroni, Marina
    NEUROLOGICAL SCIENCES, 2025,
  • [27] DO MULTIPLE TREATMENT CYCLES WITH ANTI-CGRP MONOCLONAL ANTIBODIES MODIFY MIGRAINE COURSE?
    Aurilia, C.
    Egeo, G.
    Proietti, S.
    Torelli, P.
    Cevoli, S.
    D'Onofrio, F.
    Bonassi, S.
    Barbanti, P.
    HEADACHE, 2023, 63 : 126 - 126
  • [28] Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study
    Braca, S.
    Russo, C.
    Miele, A.
    Stornaiuolo, A.
    Sansone, M.
    De Simone, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 376 - 376
  • [29] Treatment with anti-CGRP monoclonal antibodies in patients with idiopathic intracranial hypertension: a pilot study
    Krajnc, N.
    Macher, S.
    Marik, W.
    Michl, M.
    Novak, K.
    Woeber, C.
    Pemp, B.
    Bsteh, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 485 - 486
  • [30] Concomitant treatment of anti-CGRP and botulinum toxin in resistant migraine, is it useful for our patients?
    Nieves Castellanos, C.
    Olivier, M.
    Fabrich Marin, M. I.
    Insa, S. Diaz
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345